+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Design of inhibitors for nucleoside hydrolase from Leishmania donovani using molecular dynamics studies

Design of inhibitors for nucleoside hydrolase from Leishmania donovani using molecular dynamics studies

Journal Of The Brazilian Chemical Society: 1, 64-73

In this work we propose the first homology model for nucleoside hydrolase from <i>Leishmania donovani</i>, built based on the crystallographic structures of <i>Crithidia fasciculata</i> and <i>Leishmania major</i> nucleoside hydrolases.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 030841647

Download citation: RISBibTeXText

Related references

Kinetics and docking studies of two potential new inhibitors of the nucleoside hydrolase from Leishmania donovani. European Journal of Medicinal Chemistry 56: 301-307, 2012

Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from Bacillus anthracis. Journal of Biomolecular Structure and Dynamics 28(4): 455-469, 2011

Evaluation of the nucleoside hydrolase 36 of Leishmania donovani as a recombinant or DNA vaccine against Leishmania mexicana. American Journal of Tropical Medicine and Hygiene 69(3 Suppl.): 583, 2003

Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains. Frontiers in Immunology 5: 189, 2014

Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection. Frontiers in Immunology 5: 273, 2014

Identification of Novel Inhibitors of Leishmania donovani γ-Glutamylcysteine Synthetase Using Structure-Based Virtual Screening, Docking, Molecular Dynamics Simulation, and in Vitro Studies. Journal of Chemical Information and Modeling 57(4): 815-825, 2017

Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani. Vaccine 24(22): 4863-4873, 2006

Cloning and characterization of Leishmania donovani inosine uridine nucleoside hydrolase. Memorias do Instituto Oswaldo Cruz 94(Suppl. 2): 151, 1999

Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis. Molecular and Biochemical Parasitology 120(2): 315-319, 2002

A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite. Gene 280(1-2): 153-162, 2001

Expression and purification of an engineered, yeast-expressed Leishmania donovani nucleoside hydrolase with immunogenic properties. Human Vaccines and Immunotherapeutics 12(7): 1707-1720, 2016

Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 35(1): 141-158, 2017

Anti-parasite activity of nucleoside analogues: the metabolism of carbocyclic inosine in promastigotes of Leishmania tropica and Leishmania donovani and its activity against amastigotes of Leishmania donovani in vitro. Nucleic Acids Symposium Series 1986(17): 149-151, 1986

Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis. Protein Expression and Purification 130: 129-136, 2017

Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation. Journal of Molecular Modeling 17(11): 2939-2951, 2011